Direction of new drug research:soft regulation of inflammatory immune responses
2017-01-16 03:42:51WeiWEI
中國(guó)藥理學(xué)與毒理學(xué)雜志 2017年10期
Wei WEI
(Institute of Clinical Pharmacology,Anhui Medical University,Key Laboratory of Anti-inflammatory and Immune Medicine,Ministry of Education,Anhui Collaborative Innovation Center of Anti-inflammatory and Immune Medicine,Hefei 230032,China）
中國(guó)藥理學(xué)與毒理學(xué)雜志2017年10期
- 中國(guó)藥理學(xué)與毒理學(xué)雜志的其它文章
- Identification and optimization of a potent and highly selective D3 dopamine receptor agonist
- Protective role of FoxO transcription factors against oxidative stress-induced chondrocyte dysfunction:a new therapeutic target for osteoarthritis
- Meta-analysis of serum copper and heart failure
- Involvement of cysteinyl leukotriene signaling in microglial morphological changes and CASP1 expression in vitro
- Inhibitory effect of compound NS5806 on cardiac transient outward potassium channel dependents on interaction between auxiliary subunits
- Connexin 40-formed GJIC increases the phototoxicity of photodynamic therapy through ROS-and calcium-mediated pathways